References
- Sekeres-Bartho. Immunosuppressionby progester-one in pregnancy. Boca Raton: CRC Press, 1992
- Daya S, Ward S, Burrows E. Progesterone profiles in luteal phase defect cycles and outcome ofproges-terone treatment in patients with recurrent sponta-neous abortion. Am J Obstet Gynecol 1988;158: 225–32
- Daily CA, Laurent SL, Nunley WC. The prognos-tic value of serum progesterone and quantitative I3-human chorionic gonadotropin in early human pregnancy. Am J Obstet Gynecol 1994;171: 380–4
- Long CA, Lincoln SR, Whitworth NS, Cowan BD. Progesterone concentration as a predictor of pregnancy normalcy is most useful when hCG levels are less than 2000 mIU/ml. J Assist Reprod Genet 1995;12:195–97
- Isaacs JD, Whitworth NS, Cowan BD. Relative operating characteristic analysis in reproductive medicine: comparison of progesterone and human chorionic gonadotropin doubling time as predic-tors of early gestational normalcy. Fertil Steril 1994; 62:452–5.
- Marthy YS, Arronet GH, Parekh MC. Luteal phase inadequacy: its significance in infertility. Obstet Gynecol 1970;36:758–61
- Formigli L, Roccio C, Belotti G, et al. Oocyte donation by gamete intrafallopian transfer to amenorrheic and cycling patients given replace-ment steroids. Hum Reprod 1989;4:772–6
- Philipp K, Leodolter S, Miiller-Tyl E, et al. Zur Frage einer prophylaktischen Schwangerschafts-schutzmedikation bei Frauen mit erfolgreich behandelter Sterilität. Wien Klin Wschr 1978;18: 670–2
- Check JH, Chase JS, Nowroozi K, et al. Progester-one therapy to decrease first trimester spontaneous abortion in previous aborters. Int J Fertil 1987;32: 192–9
- Smitz J, Devroey P, Faguer B, et al. A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Hum Reprod 1992;7:168–75
- Feinberg BB, Tan NS, Gonik B, et al. Increased progesterone concentrations are necessary to sup-press interleukin-2-activated human mononuclear cell cytotoxicity. Am J Obstet Gynecol 1991;165: 1872–6
- Stephenson DC. Progesterone and immuno-suppression during pregnancy. Adv Contracept Delivery Syst 1990;6:332–45
- Stites DP, Bugbee S, Siiteri P. Differential actions of progesterone and cortisone on lymphocyte and monocyte interaction during lymphocyte activation — relevance to immunosuppression in pregnancy. J Reprod Immunol 1993;5:215–28
- Clemens LE, Siiteri PK, Stites DP. Mechanism of immunosuppression of progesterone on maternal lymphocyte activation during pregnancy. J Immunol 1979;122:1978–85
- SepOld M, Koistinen R, Rutanen EM. Uterine endocrinolgy and paracrinology: insulin-like growth factor binding protein-1 and placental pro-tein 14 revisited. Hum Reprod 1994;9\(Suppl 2): 96–106
- Miyauchi A, Osuga Y, Taketani Y. Effects of ste-roid hormones on fibrinolytic system in cultured human endometrial cells. Endocr J 1995;42:57–62
- Fraser EJ, Grimes DA, Schulz KF. Immunization as therapy for recurrent spontaneous abortion. A review and meta-analysis. Obstet Gynecol 1993;82: 854–9
- The Recurrent Miscarriage Immunotherapy Trialists Group. Worldwide collaborative observa-tional study and meta-analysis on allogenic leuko-cyte immunotherapy for recurrent spontaneous abortion. AJRI 1994;32:55–72
- Gerhard I, Daniel V, Runnebaum B. Habitueller Abort. 1. Ursachen Gynakol Prax 1996;20: 13–24
- Loke Y. Immunology of human implantation. Presented at the 13th Annual Meeting of the European Society of Human Reproduction and Embryology, Edin-burgh, 22–25 June 1997